Pel 1850pe buy @ 62-64, tgt ram bharose, sl Ggg bharose 50👈😂
forum
PEL Share Price Discussion
Piramal Enterprises Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
PEL Share Price *
1,824 -2.4 (-0.13%)
* (quote may be delayed)
PEL Discussion Forum
Pel trading at 1904 , it will go up only from here
Like
reply
Reply (1)
share
Share
Latest replies
1914
Buy pel 1950 ce @40.75 tgt 49 sl 39
42.05
Like
reply
Reply (2)
share
Share
Latest replies
42.25🔥
44.20🔥
Stocks in the news: DLF, Aavas Financiers, TCS, NBCC, Kaveri Seed, Wipro, Mindtree, TRF
DLF, Aavas Financiers, TCS, NBCC, Wipro, Mindtree
DLF, Aavas Financiers, TCS, NBCC, Wipro, Mindtree
Moneycontrol
Like
reply
Reply
share
Share
Stocks in the news: Bharat Electronics, Monsanto, Bayer Crop, Andhra Bank, Prabhat Dairy, Canara Bank
Bharat Electronics | Monsanto India | Bayer Crop | Andhra Bank and Indian Bank are stocks which are in news today.
Bharat Electronics | Monsanto India | Bayer Crop | Andhra Bank and Indian Bank are stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Stocks in the news: Bharat Electronics, Monsanto, Bayer Crop, Andhra Bank, Indian Bank
Bharat Electronics | Monsanto India | Bayer Crop | Andhra Bank and Indian Bank are stocks which are in news today.
Bharat Electronics | Monsanto India | Bayer Crop | Andhra Bank and Indian Bank are stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Trade Setup for Monday: Top 15 things to know before Opening Bell
Market is expected to undergo profit booking from current levels and any upmove could be a bull trap, say analysts
Market is expected to undergo profit booking from current levels and any upmove could be a bull trap, say analysts
Moneycontrol
Like
reply
Reply
share
Share
link
Motilal Oswal Financial Services
BSE SENSEX 37,104 S&P CNX 10,983 Piramal Enterprises CMP: INR1,965 Moderating growth 12 September 2019 Annual Report Update | Sector: Financials - NBFC TP: INR2,400 (+22%) Buy Financial Services’ domination increases The liquidity crisis, lag impact of demonetization, RERA implementation and stress in the Real Estate financing space has weighed down the growth of PIEL’s Financial Services (FS) business. FY19 saw PIEL’s customer assets grow by 34% YoY to INR566b v/s 50%+ in the past few years. Nevertheless, dominance of FS in overall revenue and operating profitability continue to rise with share of 53%/67% v/s 47%/67% in FY18. Pressure on margins (partially led by move towards low yielding Retail Housing loans) and cost of Retail rollout weighed on profitability. ROAs declined ~50bp to 3.1%. Stress loans increased with stage 2/3 loan share at 1.9% v/s 0.9% a year ago. Outstanding provisions on the balance sheet stand at 1.8% of loans (stable YoY). Real estate share of the loan book is down to 71.6% YoY v/s 75.9% a year ago, helped by sharp rise in the share of Retail Housing loans (9.5% v/s 2.9% a year ago). In the FS business, banks (71%), mutual funds (11%) and insurance companies (8%) are the largest sources of funding. The share of CPs is down to 12% v/s 18% a year ago. At consolidated level, the mix between floating and fixed rate borrowing is 75:25 v/s 43:57 a year ago and at the FS business level, it is 60:40 v/s 50:50 a year ago. From an Asset Liability Management (ALM) perspective, ~84% (~90% in FY18) of liabilities mature within three years, while ~55% (~58% in FY18) of assets mature during the same period. Networth allocation disclosure: (a) FS business at INR114b; (b) Pharma and IT business at INR50b; (c) Shriram group’s outstanding value at INR72b; and (d) the rest is DTA related with networth of INR36b. Outstanding aggregate debt of Pharma and IT business stands at ~INR95b. Pharma business: PIEL has implemented multiple initiatives for improvement in margins, thereby resulting in global EBITDA margin increasing from 14% in FY13 to 23% in FY19. Domestic pharma business continues to show moderation and remains a drag on overall pharma business’ profitability. Company sold the Imaging business and booked loss of INR4.5b (pre-tax) at the consolidated level and INR12.9b (pretax) at the standalone level (including investment write-off of INR8.4b) In the current environment, PIEL is focusing on (a) reducing key large exposures such as Lodha, Wadhwa and Omkar, (b) reducing share of short-term borrowings, and (c) diversifying the loan mix to lower risk assets. The company also plans to raise capital to reduce leverage – this would help lower its cost of funds in the Financing business, which is currently elevated at 10.3%. Considering the challenging environment, we expect the company to keep higher capitalization and liquidity on the balance sheet. Buy with TP of INR2,400 (FY21E SOTP-based). Bloomberg Equity Shares (m) M.Cap.(INRb)/(USDb) 52-Week Range (INR) 1, 6, 12 Rel. Per (%) 12M Avg Val (INR M) Free float (%) PIEL IN 199 392.1 / 5.5 3054 / 1652 14/-23/-31 1763 53.9 2021E 181.5 48.8 25.4 127.3 23.7 1,424 35.0 19.0 1.7 1.9 Financials Snapshot (INR b) Y/E March 2019 2020E Revenues 132.2 153.6 EBITDA 36.6 42.2 PAT 14.7 20.5 EPS (INR) 73.7 102.9 EPS Gr. (%) BV/Sh. (INR) Payout (%) Valuations P/E (x) P/BV (x) Div. Yield (%) -5.2 1,275 38.0 32.8 1.9 1.2 39.5 1,342 29.2 23.5 1.8 1.3 Shareholding pattern (%) As On Jun-18 Mar-18 Jun-17 Promoter 50.8 51.4 51.4 DII 4.4 3.8 3.6 FII 27.5 28.0 28.7 Others 17.3 16.8 16.3 FII Includes depository receipts Stock Performance (1-year) Piramal Enterp. Sensex - Rebased 3,300 2,700 2,100 1,500 Research Analyst: Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com); +91 22 6129 1526 / Tushar Manudhane (Tushar.Manudhane@motilaloswal.com); +91 22 6129 1519 Piran Engineer (Piran.Engineer@MotilalOswal.com); +91 22 6129 1539/ Ashish Chopra (Ashish.Chopra@MotilalOswal.com); +91 22 6129 1530 Investors are advised to refer through important disclosures made at the last page of the Research Report. Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
BSE SENSEX 37,104 S&P CNX 10,983 Piramal Enterprises CMP: INR1,965 Moderating growth 12 September 2019 Annual Report Update | Sector: Financials - NBFC TP: INR2,400 (+22%) Buy Financial Services’ domination increases The liquidity crisis, lag impact of demonetization, RERA implementation and stress in the Real Estate financing space has weighed down the growth of PIEL’s Financial Services (FS) business. FY19 saw PIEL’s customer assets grow by 34% YoY to INR566b v/s 50%+ in the past few years. Nevertheless, dominance of FS in overall revenue and operating profitability continue to rise with share of 53%/67% v/s 47%/67% in FY18. Pressure on margins (partially led by move towards low yielding Retail Housing loans) and cost of Retail rollout weighed on profitability. ROAs declined ~50bp to 3.1%. Stress loans increased with stage 2/3 loan share at 1.9% v/s 0.9% a year ago. Outstanding provisions on the balance sheet stand at 1.8% of loans (stable YoY). Real estate share of the loan book is down to 71.6% YoY v/s 75.9% a year ago, helped by sharp rise in the share of Retail Housing loans (9.5% v/s 2.9% a year ago). In the FS business, banks (71%), mutual funds (11%) and insurance companies (8%) are the largest sources of funding. The share of CPs is down to 12% v/s 18% a year ago. At consolidated level, the mix between floating and fixed rate borrowing is 75:25 v/s 43:57 a year ago and at the FS business level, it is 60:40 v/s 50:50 a year ago. From an Asset Liability Management (ALM) perspective, ~84% (~90% in FY18) of liabilities mature within three years, while ~55% (~58% in FY18) of assets mature during the same period. Networth allocation disclosure: (a) FS business at INR114b; (b) Pharma and IT business at INR50b; (c) Shriram group’s outstanding value at INR72b; and (d) the rest is DTA related with networth of INR36b. Outstanding aggregate debt of Pharma and IT business stands at ~INR95b. Pharma business: PIEL has implemented multiple initiatives for improvement in margins, thereby resulting in global EBITDA margin increasing from 14% in FY13 to 23% in FY19. Domestic pharma business continues to show moderation and remains a drag on overall pharma business’ profitability. Company sold the Imaging business and booked loss of INR4.5b (pre-tax) at the consolidated level and INR12.9b (pretax) at the standalone level (including investment write-off of INR8.4b) In the current environment, PIEL is focusing on (a) reducing key large exposures such as Lodha, Wadhwa and Omkar, (b) reducing share of short-term borrowings, and (c) diversifying the loan mix to lower risk assets. The company also plans to raise capital to reduce leverage – this would help lower its cost of funds in the Financing business, which is currently elevated at 10.3%. Considering the challenging environment, we expect the company to keep higher capitalization and liquidity on the balance sheet. Buy with TP of INR2,400 (FY21E SOTP-based). Bloomberg Equity Shares (m) M.Cap.(INRb)/(USDb) 52-Week Range (INR) 1, 6, 12 Rel. Per (%) 12M Avg Val (INR M) Free float (%) PIEL IN 199 392.1 / 5.5 3054 / 1652 14/-23/-31 1763 53.9 2021E 181.5 48.8 25.4 127.3 23.7 1,424 35.0 19.0 1.7 1.9 Financials Snapshot (INR b) Y/E March 2019 2020E Revenues 132.2 153.6 EBITDA 36.6 42.2 PAT 14.7 20.5 EPS (INR) 73.7 102.9 EPS Gr. (%) BV/Sh. (INR) Payout (%) Valuations P/E (x) P/BV (x) Div. Yield (%) -5.2 1,275 38.0 32.8 1.9 1.2 39.5 1,342 29.2 23.5 1.8 1.3 Shareholding pattern (%) As On Jun-18 Mar-18 Jun-17 Promoter 50.8 51.4 51.4 DII 4.4 3.8 3.6 FII 27.5 28.0 28.7 Others 17.3 16.8 16.3 FII Includes depository receipts Stock Performance (1-year) Piramal Enterp. Sensex - Rebased 3,300 2,700 2,100 1,500 Research Analyst: Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com); +91 22 6129 1526 / Tushar Manudhane (Tushar.Manudhane@motilaloswal.com); +91 22 6129 1519 Piran Engineer (Piran.Engineer@MotilalOswal.com); +91 22 6129 1539/ Ashish Chopra (Ashish.Chopra@MotilalOswal.com); +91 22 6129 1530 Investors are advised to refer through important disclosures made at the last page of the Research Report. Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
ow
#ResearchReport - PIRAMAL ENTERPRISES (Annual Report Update): Financial Services’ domination increases; Moderating growth. Read more at: http://ow.ly/AB2d50w7Pcl
#readresearch #marketknowledge
Like
reply
Reply
share
Share
Sell PEL @1875 Target 1750 SL 1895
Like
reply
Reply
share
Share
Dev Thakur in PELBuy Above 1982 Tgt 1998 Sl depends on u
High 1997
Like
reply
Reply
share
Share
Buy Above 1982
Tgt 1998
Sl depends on u
Like
reply
Reply
share
Share
sure means sure in PELPEL NSE CASH BUY AT CMP 1967 - 1965 SL 1955 TAR...
TARGET HIT 1988 IN PEL
Like
reply
Reply
share
Share
sure means sure in PELPEL NSE CASH BUY AT CMP 1967 - 1965 SL 1955 TAR...
1975.8 🏇🏇🏇
Like
reply
Reply
share
Share
PEL NSE CASH BUY AT CMP 1967 - 1965
SL 1955
TAR 1988
MOST LIKELY TO FLY UPSIDE
Like
reply
Reply
share
Share
11-09-19
pel BUY FUT SEP (Intraday)
only above @ 1974
Like
reply
Reply (4)
share
Share
Latest replies
high 1978
high 1979.50
high 1982.50
high 1986
Buy pel 2000 ce @ 37.50 tgt 45 sl 36
@42🔥🔥
Like
reply
Reply (4)
share
Share
Latest replies
42.35🔥
45🔥
49 🔥
63🔥
RJ ROCKET TRADES in PEL*PEL FUT BUY ABOVE 1900*
Pel guys 1919 hardluck
We cncld bid for it
Like
reply
Reply
share
Share
RJ ROCKET TRADES in PEL*PEL FUT BUY ABOVE 1900*
*Remove pel bid*
*As level not coming*
Like
reply
Reply
share
Share
*PEL FUT BUY ABOVE 1900*
Like
reply
Reply
share
Share
Ggg in PEL1850pe Pel @ 56-58, tgt open, sl 40
Pel 1850pe 56 to 72 & couting.... Do ur wrk on buking profits accordingly & yes 1 more imp thing i won't revert to calls wer sl tgt provided so don't huk or fck my peace by asking shitty questing👈
Like
reply
Reply
share
Share
Ggg in PELSell Pel fut @ 1898, tgt below 1830, sl 1910
Pel fut 1898 to 1863 & couting....
Like
reply
Reply
share
Share
Ggg in PELSell Pel fut @ 1898, tgt below 1830, sl 1910
Pel sudden 10 penny fall & now on its new inta low, just check the attitude of my view👈😝
Like
reply
Reply
share
Share
Ggg in PEL1850pe Pel @ 56-58, tgt open, sl 40
Sell Pel fut @ 1898, tgt below 1830, sl 1910
Like
reply
Reply
share
Share
Geojit Financial Services Recommendation on PEL
Date: 29-Aug-19
Broker: Geojit Financial Services
Price @ Call: 1918.57
Target: 2119
Recommendation: BUY
Like
reply
Reply
share
Share
Rupee headwinds will put pressure on equities; could retest Rs 74/$ in near term
Rupee successfully retested its multi-year breakout zone of 69 and is poised to retest its previous zone of Rs 74.5/$ and could even breach it
Rupee successfully retested its multi-year breakout zone of 69 and is poised to retest its previous zone of Rs 74.5/$ and could even breach it
Moneycontrol
Like
reply
Reply
share
Share
PEL looking good now at 2008-2010
Like
reply
Reply (1)
share
Share
Latest replies
PEL was suggested at 2008-2010. from there it made high 2050. Hope you enjoyed this call
An evening walk down D-St: Sensex falls 383 points, Nifty ends below 10,950; bank, financials top drags
Investors took money off the table as worries over the deteriorating health of the domestic economy continued weighing on their risk appetite.
Investors took money off the table as worries over the deteriorating health of the domestic economy continued weighing on their risk appetite.
Moneycontrol
Like
reply
Reply
share
Share
RJ ROCKET TRADES in PEL*BUY PEL ABOVE 1875 (CASH ONLY )*
Pel now 1945 what a badluck
Like
reply
Reply
share
Share
RJ ROCKET TRADES in PEL*BUY PEL ABOVE 1875 (CASH ONLY )*
Exit pel and wait for new trade
Like
reply
Reply
share
Share
Piramal Enterprises slips 3% after board defers NCD issue
The share touched its 52-week high Rs 3,302.55 and 52-week low Rs 1,651.80 on 31 August, 2018 and 07 August, 2019, respectively.
The share touched its 52-week high Rs 3,302.55 and 52-week low Rs 1,651.80 on 31 August, 2018 and 07 August, 2019, respectively.
Moneycontrol
Like
reply
Reply
share
Share
RJ ROCKET TRADES in PEL*BIG BUY PEL NOW GUYS FAST*
1855sl in pel tg 1900
Like
reply
Reply
share
Share
RJ ROCKET TRADES in PEL*BUY PEL ABOVE 1875 (CASH ONLY )*
*BIG BUY PEL NOW GUYS FAST*
Like
reply
Reply
share
Share
*BUY PEL ABOVE 1875 (CASH ONLY )*
Like
reply
Reply
share
Share
Stocks in the news: Nestle, Lakshmi Vilas Bank, Hexaware, Just Dial, Indiabulls Housing, JMC Projects
Lakshmi Vilas Bank | Hexaware Technologies | Just Dial | Indiabulls Housing Finance and L&T Finance Holdings are stocks which are in the news today.
Lakshmi Vilas Bank | Hexaware Technologies | Just Dial | Indiabulls Housing Finance and L&T Finance Holdings are stocks which are in the news today.
Moneycontrol
Like
reply
Reply
share
Share
Stocks in the news: Nestle, Lakshmi Vilas Bank, Hexaware, Just Dial, Indiabulls Housing
Lakshmi Vilas Bank | Hexaware Technologies | Just Dial | Indiabulls Housing Finance and L&T Finance Holdings are stocks which are in the news today.
Lakshmi Vilas Bank | Hexaware Technologies | Just Dial | Indiabulls Housing Finance and L&T Finance Holdings are stocks which are in the news today.
Moneycontrol
Like
reply
Reply
share
Share
Ashish TiwariSell PEL @ 1912 sl 1928
Call active
Like
reply
Reply
share
Share
Stocks in the news: Adani Ports, Alkem Lab, Cupid, NCL Industries, Lakshmi Vilas Bank
Dynamatic Technologies | Bandhan Bank | Ipca Laboratories | Indiabulls housing Finance | Piramal Enterprises and DHFL are stocks, which are in news today.
Dynamatic Technologies | Bandhan Bank | Ipca Laboratories | Indiabulls housing Finance | Piramal Enterprises and DHFL are stocks, which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Trade Setup for Monday: Top 15 things to know before Opening Bell
The Sensex was up 228.23 points at 36,701.16, while Nifty was up 88.00 points at 10,829.40.
The Sensex was up 228.23 points at 36,701.16, while Nifty was up 88.00 points at 10,829.40.
Moneycontrol
Like
reply
Reply
share
Share
LONG PEL CMP 1758 SL 1429 TGT 1780-1800-1840
1
reply
Reply (3)
share
Share
Latest replies
FROM 1758 TO 1771 ENJOY
from 1758 to 1785 enjoy FM meet if you are safe player dont hold book profit am holding
#jackpot from 1758 to 1906 enjoy and book
Buy PEL 1700 pe at 22-23
Target 38-45+
Sl below 16
Like
reply
Reply
share
Share
Top 30 stocks that fund managers bought & sold in July; do you own any?
Oil India, which was in the top 10 sell list in June, has moved to the top 10 buy list in July.
Oil India, which was in the top 10 sell list in June, has moved to the top 10 buy list in July.
Moneycontrol
Like
reply
Reply
share
Share
Short PEL FUT at 1771
Target 1740
Sl above 1779
Like
reply
Reply (1)
share
Share
Latest replies
Stop loss hit
Buy PEL 1750 pe at 43.5-44.4
Target 58-65-71+
Sl below 38
Like
reply
Reply
share
Share
19-08-19
PEL BUY FUT AUG (Intraday)
only above @ 1820
Like
reply
Reply (2)
share
Share
Latest replies
High 1823 *****
High 1826 ******
Sure TradesSell Pel below 1762 Stoploss 1772 Target 1751/1741+
1756🔥🔥
Like
reply
Reply
share
Share
- NewsBotYesterday 1:53 PMStocks in the news: DLF, Aavas Financiers, TCS, NBCC, Kaveri Seed, Wipro, Mindtree, TRFMoneycontrolNewsBotSep 16 1:43 PMStocks in the news: Bharat Electronics, Monsanto, Bayer Crop, Andhra Bank, Prabhat Dairy, Canara BankMoneycontrolNewsBotSep 16 1:28 PMStocks in the news: Bharat Electronics, Monsanto, Bayer Crop, Andhra Bank, Indian BankMoneycontrolNewsBotSep 16 12:13 AMTrade Setup for Monday: Top 15 things to know before Opening BellMoneycontrolNewsBotSep 1 2:23 PMRupee headwinds will put pressure on equities; could retest Rs 74/$ in near termMoneycontrolNewsBotAug 29 11:18 PMAn evening walk down D-St: Sensex falls 383 points, Nifty ends below 10,950; bank, financials top dragsMoneycontrolNewsBotAug 29 3:38 PMPiramal Enterprises slips 3% after board defers NCD issueMoneycontrolNewsBotAug 29 1:43 PMStocks in the news: Nestle, Lakshmi Vilas Bank, Hexaware, Just Dial, Indiabulls Housing, JMC ProjectsMoneycontrolNewsBotAug 29 1:18 PMStocks in the news: Nestle, Lakshmi Vilas Bank, Hexaware, Just Dial, Indiabulls HousingMoneycontrolNewsBotAug 26 2:03 PMStocks in the news: Adani Ports, Alkem Lab, Cupid, NCL Industries, Lakshmi Vilas BankMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.